Therapeutic drug monitoring in inflammatory bowel disease treatments

doi:10.3748/wjg.v28.i15.1604

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 15

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2847)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

249

WORD

HTML

1569

Sum=1876

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

314

Download

657

Sum=971

Apr 21, 2022 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. Apr 21, 2022; 28(15): 1604-1607
Published online Apr 21, 2022. doi: 10.3748/wjg.v28.i15.1604

Therapeutic drug monitoring in inflammatory bowel disease treatments

Meng-Yao Wang, Jing-Wen Zhao, Chang-Qing Zheng, Li-Xuan Sang

Meng-Yao Wang, Jing-Wen Zhao, Chang-Qing Zheng, Li-Xuan Sang, Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China

Author contributions: Wang MY and Zhao JW wrote the letter; Sang LX and Zheng CQ supervised the manuscript drafting; each author contributed important intellectual content during manuscript drafting and revision.

Conflict-of-interest statement: Nothing to declare.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Li-Xuan Sang, MD, PhD, Associate Professor, Department of Gastroenterology, Shengjing Hospital of China Medical University, No. 39 Gliding Road, Tiexi District, Shenyang 110022, Liaoning Province, China. sanglixuan2008@163.com

Received: October 21, 2021
Peer-review started: October 21, 2021
First decision: December 27, 2021
Revised: January 6, 2022
Accepted: March 16, 2022
Article in press: March 16, 2022
Published online: April 21, 2022

Core Tip

Core Tip: Therapeutic drug monitoring (TDM) has proven to be useful in the management of patients with inflammatory bowel disease (IBD). The therapeutic value, feasibility and application prospect of TDM in the treatment of IBD were discussed.